oncology
-
Biotech
Ex-Novartis Oncology CEO Barrett joins UroGen
Ex-Novartis Oncology CEO Liz Barrett has joined UroGen Pharma. Barrett is taking on as CEO of the uro-oncology specialist at…
Read More » -
Biotech
Innovent buys Chinese rights to Incyte drugs for $40M upfront
Innovent Biologics has bagged the Chinese rights to three clinical-phase oncology and hematology drugs in growth at Incyte. The agreement…
Read More »